tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Similar Stocks

Compare
839 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immunovant
$15.49
$2.68B
-42.20%
10 Buy
2 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$54.66
$3.39B
71.85
68.34%
8 Buy
0 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$41.58
$3.57B
-32.70%
14 Buy
6 Hold
0 Sell
Moderate Buy
Apellis Pharmaceuticals
$18.30
$2.37B
-54.62%
12 Buy
8 Hold
0 Sell
Moderate Buy
Scholar Rock Holding
$32.13
$3.08B
265.95%
7 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$31.77
$2.98B
-30.22%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMVT
Immunovant
15.49
-11.31
-42.20%
PTGX
Protagonist Therapeutics
54.66
22.19
68.34%
CRSP
Crispr Therapeutics AG
41.58
-20.20
-32.70%
APLS
Apellis Pharmaceuticals
18.30
-22.03
-54.62%
SRRK
Scholar Rock Holding
32.13
23.35
265.95%
CRNX
Crinetics Pharmaceuticals
31.20
-13.51
-30.22%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis